Want to talk?
800.672.0676 | 215.525.9800
Together, technological advancements and tectonic shifts in the healthcare delivery model are pushing us toward an emerging health economy in which pharma marketers increasingly focus their efforts on each patient as a “Segment of One.” In this new segment-of-one model, businesses must maximize value by creating a more personalized experience. Download this white paper to understand and embrace the segment-of-one opportunities that will become the foundation of a successful go-to-market plan.
Rare diseases afflict as many as 30 million Americans, nearly 10% of the US population. As midsize and large pharmaceutical companies began to realize the revenue potential of orphan drugs, they started to increase their investment in the market. That orphan drug marketplace continues to represent a significant opportunity for research-based biopharmaceutical firms. Learn more about the opportunities and challenges in marketing orphan drugs as well as the stakeholders involved with this free whitepaper from Publicis Touchpoint Solutions.
The next generation of sales, marketing and technology beyond multichannel marketing and omnichannel marketing is Orchestrated Customer Engagement (OCE) and its goal is to improve the relationship between Life Sciences companies and their customers, increase efficiencies across all channels of communication and boost ROI. Read more in this IMS Health white paper featuring several industry thought leaders, including Mark J. Stevens, SVP Strategy & Commercial Effectiveness at Publicis Touchpoint Solutions. Used with permission.
Oncologists are facing unprecedented pressures as both clinicians and business managers. This white paper provides insights into the challenges oncologists face and the action steps necessary to deliver superior results.